Turning anti-ageing genes against cancer

Valter D. Longo; Michael R. Lieber; Jan Vijg

doi:10.1038/nrm2526

Turning anti-ageing genes against cancer

Valter D. Longo, Michael R. Lieber, Jan Vijg

Genetics

Research output: Contribution to journal › Comment/debate › peer-review

32 Scopus citations

Abstract

Recent studies in diverse organisms implicate proto-oncogenic pathways, including insulin-like growth factor-I (IGF-I), Ras and AKT/protein kinase B in the ageing process. Although IGF-I is thought to contribute to cancer by promoting growth and preventing apoptosis, evidence from model organisms suggests that proto-oncogene homologues might contribute to the DNA mutations and chromosomal damage that are observed in tumour cells by increasing DNA damage, in both dividing and non-dividing cells, and involving error-prone systems in DNA repair. This raises the possibility that cancer can be reduced by chronic downregulation of pro-ageing pathways.

Original language	English (US)
Pages (from-to)	903-910
Number of pages	8
Journal	Nature Reviews Molecular Cell Biology
Volume	9
Issue number	11
DOIs	https://doi.org/10.1038/nrm2526
State	Published - Nov 2008

ASJC Scopus subject areas

Molecular Biology
Cell Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nrm2526

Cite this

@article{102ee0368dc642e4873a504d0c907caa,

title = "Turning anti-ageing genes against cancer",

abstract = "Recent studies in diverse organisms implicate proto-oncogenic pathways, including insulin-like growth factor-I (IGF-I), Ras and AKT/protein kinase B in the ageing process. Although IGF-I is thought to contribute to cancer by promoting growth and preventing apoptosis, evidence from model organisms suggests that proto-oncogene homologues might contribute to the DNA mutations and chromosomal damage that are observed in tumour cells by increasing DNA damage, in both dividing and non-dividing cells, and involving error-prone systems in DNA repair. This raises the possibility that cancer can be reduced by chronic downregulation of pro-ageing pathways.",

author = "Longo, {Valter D.} and Lieber, {Michael R.} and Jan Vijg",

note = "Funding Information: Related work in the laboratory of V.D.L. has been supported by an American Federation for Aging Research (AFAR) grant, by National Institutes of Health (NIH) grant AG20642 and AG025135, and by a Norris Cancer Center pilot grant. Related work has been supported by AG17242, AG20438, ES11044 and Ellison grant AG-SS-1496-05 in the laboratory of J.V. and by NIH grant CA100504 in the laboratory of M.R.L.",

year = "2008",

month = nov,

doi = "10.1038/nrm2526",

language = "English (US)",

volume = "9",

pages = "903--910",

journal = "Nature Reviews Molecular Cell Biology",

issn = "1471-0072",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Turning anti-ageing genes against cancer

AU - Longo, Valter D.

AU - Lieber, Michael R.

AU - Vijg, Jan

N1 - Funding Information: Related work in the laboratory of V.D.L. has been supported by an American Federation for Aging Research (AFAR) grant, by National Institutes of Health (NIH) grant AG20642 and AG025135, and by a Norris Cancer Center pilot grant. Related work has been supported by AG17242, AG20438, ES11044 and Ellison grant AG-SS-1496-05 in the laboratory of J.V. and by NIH grant CA100504 in the laboratory of M.R.L.

PY - 2008/11

Y1 - 2008/11

N2 - Recent studies in diverse organisms implicate proto-oncogenic pathways, including insulin-like growth factor-I (IGF-I), Ras and AKT/protein kinase B in the ageing process. Although IGF-I is thought to contribute to cancer by promoting growth and preventing apoptosis, evidence from model organisms suggests that proto-oncogene homologues might contribute to the DNA mutations and chromosomal damage that are observed in tumour cells by increasing DNA damage, in both dividing and non-dividing cells, and involving error-prone systems in DNA repair. This raises the possibility that cancer can be reduced by chronic downregulation of pro-ageing pathways.

AB - Recent studies in diverse organisms implicate proto-oncogenic pathways, including insulin-like growth factor-I (IGF-I), Ras and AKT/protein kinase B in the ageing process. Although IGF-I is thought to contribute to cancer by promoting growth and preventing apoptosis, evidence from model organisms suggests that proto-oncogene homologues might contribute to the DNA mutations and chromosomal damage that are observed in tumour cells by increasing DNA damage, in both dividing and non-dividing cells, and involving error-prone systems in DNA repair. This raises the possibility that cancer can be reduced by chronic downregulation of pro-ageing pathways.

UR - http://www.scopus.com/inward/record.url?scp=54549116989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54549116989&partnerID=8YFLogxK

U2 - 10.1038/nrm2526

DO - 10.1038/nrm2526

M3 - Comment/debate

C2 - 18946478

AN - SCOPUS:54549116989

SN - 1471-0072

VL - 9

SP - 903

EP - 910

JO - Nature Reviews Molecular Cell Biology

JF - Nature Reviews Molecular Cell Biology

IS - 11

ER -

Turning anti-ageing genes against cancer

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this